Skip to content

Medtech Women Advisory Board

SE Medtech Women is a group dedicated to enhancing opportunities for women in the medtech industry. The Advisory Board represents an impressive group of women from industry, medicine, and academia that are passionate about supporting women at all levels in their careers.  


CEO – Global Center for Medical Innovation (GCMI)

Tiffany Wilson

Tiffany has spent more than 15 years bringing innovative medical technology from benchtop to bedside. She joined GCMI in 2011 to lead its startup phase, establishing overall strategic vision, building strategic relationships and bringing together key stakeholders of the medical device ecosystem. Her strong background in medical devices, commitment to fostering innovation and understanding of business strategies have propelled her into a leadership role in the Southeast and brought her into the national spotlight.

Tiffany earned a BBA in International Business from Loyola University and an MBA from Georgetown University McDonough School of Business. Wilson joined GCMI from Scientific Intake, where she served as the Vice President of Business Development and Strategy, evaluating marketing and distribution opportunities and driving product development projects for the global obesity market. Prior to Scientific Intake, she was Vice President of Corporate Strategy and Finance at ACell, Inc., a regenerative medicine and tissue engineering company based in Columbia, Maryland. At ACell, she led a broad range of initiatives including corporate finance, investor relations, strategic and operational planning, business development, regulatory, and reimbursement.

Tiffany serves as Past-President of the Board of the Southeast Medical Device Association (SEMDA), Founding Member of Medtech Women @ SEMDA, Chair of the Advisory Board for GCMI’s preclinical testing facility, and the Georgia Bio Board of Directors. She is a Member of the National Advisory Council on Innovation and Entrepreneurship (NACIE) at the U.S. Department of Commerce. She led the Sponsorship Committee of the 2013 SEMDA Conference and has served as the Co-Chair of the Medical Device Subcommittee of the Metro Atlanta Chamber Bioscience Leadership Council. In 2015 Tiffany received the prestigious Georgia Bio Community Award and in 2017 was presented with the Industry Growth Award, the highest honor bestowed each year by Georgia Bio.  She was recently recognized by Inc. Magazine as one of “17 Inspiring Women to Watch in 2017” and one of Becker Hospital Review’s “110 Women in Medtech to Know in 2017”.


CEO – MMJ Labs Pain Relief

Amy Baxter

Dr. Amy Baxter directs innovation, invention, operations and strategy for Pain Care Labs. Accomplishments include the 2009 1.1M NIH SBIR, writing and overseeing patent strategy, and successfully pursuing 510K FDA clearances.

After graduating from Yale University and Emory Medical School, as a double boarded pediatric emergency physician, Dr. Baxter founded PEMA Emergency Research, Scottish Rite, Children’s Healthcare of Atlanta while founding Pain Care Labs. Recognition includes Forbes Ten Healthcare Disruptors, Inc. Top Women in Tech to Watch, Top 10 Innovative and Disruptive Women in Healthcare, a Wall Street Journal “Idea Person”, and the Most Innovative CEO of 2014 from Georgia Bio. National and international lecturing highlights include MakerFaire, AARP, and TEDMED.


Program Director of Training and Education – T3 Labs

Kelley Bennett

Kelly joined T3 Labs in 2011 as a contract Coordinator for Training and Education. In her current role as Program Director, she  and her team facilitate  the educational innovation needs of early stage feasibility programs, training of thousands of physicians, and forge ties between academia, med device industry and clinicians. Bennett has 22 years of relevant industry experience in healthcare and research. Prior to joining T3 Labs, she spent 2 years at Georgia Bureau of Investigations, 9 years in the clinical setting as a surgical first assistant, and 11 years as an Operations manager for RTI Donor Services transplant services.

She holds a BS in Human Services Management with a focus in Healthcare Management, a Diploma in Surgical Technology, and several certifications for surgery and tissue banking. She has been  a member of American Association of Tissue Banks since 1996 and a current member of The Association of Bioskills Laboratory Excellence. Over the past three years Kelley has independently led and grown T3 Labs’ Training and Education Program, by incorporating and cobranding the translational services of T3 affiliates and the Georgia Biomedical Community.


Managing Director – Health Research Partnerships at Georgia Tech

Sherry Farrugia

Sherry Farrugia is the Managing Director for Health Research Partnerships at Georgia Tech and Director of the Pediatric Technology Center, a research collaboration between Georgia Tech and Children’s Healthcare of Atlanta. In this dual role she works to build and sustain public-private partnerships, and spends half her time at Georgia Tech and the other half at Children’s Healthcare of Atlanta where she manages the multi- million research portfolio. Farrugia has nearly 25 years experience in the Health IT field, working in data analytics, data visualization, and clinical and financial outcomes. She owned a health IT company that she sold to McKesson HBOC, and was involved in several other successful start up companies.

Before coming to Georgia Tech she owned a healthcare consulting company focusing on predictive health and risk mitigation in the area of chronic disease prediction, prevention, and management.

Farrugia is a member of: TAG Health Board, Gwinnett Tech HIT Advisory Board, an active member of the Bioscience HIT council at the Metro Atlanta Chamber of Commerce, Health Connect South Advisory Board, HIT Leadership Summit Innovation Committee, HIMSS, Atlanta Ronald McDonald House Charities Advisory Council, and Emory Board of Visitors. Ms. Farrugia received her B.S. in Chemistry with a minor in Physics from Auburn University.


Associate Director – MUSC Foundation for Research Development

Jessee Goodwin

Dr. Goodwin is the Deputy Director of the MUSC Foundation for Research Development (FRD), which serves as the technology transfer office for the Medical University of South Carolina. She is also the Technology Development Officer for the South Carolina Translational Research Institute (SCTR). In these capacities, Dr. Goodwin supports the translation of university innovations into products that improve patient care. A primary responsibility is in the management of the university’s patent portfolio, which was ranked 4thin Pipeline Power by IEEE in 2014. She came to the position from a Boston-based Intellectual Property search and analysis firm where she served as the Medical Device Group Leader.

Prior to that, Dr. Goodwin completed a post-doctoral fellowship at the Harvard-MIT Division of Health Sciences and Technology, where she was awarded an NIH fellowship. She holds a Ph.D. in Biomedical Engineering from Stony Brook University.


President – Crackerjack Marketing

Lynn Hood

Lynn Hood runs Crackerjack Marketing, an integrated marketing and communications firm focused on helping medical device, health IT, high tech and business‐to‐business companies strategically position themselves and increase awareness and sales. She began her career as a reporter for a daily newspaper and her experience ranges from writing about best practices at nuclear power plants, to advertising campaigns for mobile phones, to creating internal communications programs that empower and motivate employees. She holds an ABJ from the University of Georgia.

An Atlanta native, Lynn is passionate about supporting the growth of the city, the state and the region, particularly in bioscience and health IT. She was a founding sponsor and 10-year board member of the Southeastern Medical Device Association (SEMDA) and is a member of the Board of Directors for the Technology Association of Georgia/Health. As a member of the Board of Advisors for the Metro Atlanta Chamber, she has chaired and/or co-chaired marketing committees for both health IT and medical devices, helping formulate the messaging and proof points positioning Atlanta as the nation’s health IT capital. She has been involved with the marketing for 10 SEMDA Conferences and five Health IT Leadership Summits, and provides marketing and public relations services for a number of bioscience and health IT companies. While she regularly works with global companies, Lynn has a soft spot for start-ups and enjoys helping them leverage limited resources to achieve outstanding results.


Assistant Professor of Cardiology – Emory University

Rebecca Levit

Dr. Rebecca Levit is an Assistant Professor of Cardiology at Emory University in Atlanta, Georgia and adjunct faculty in the Department of Biomedical Engineering at the Georgia Institute of Technology. She completed her undergraduate training at Dickinson College in Carlisle, PA and medical school at The University of Pennsylvania School of Medicine in Philadelphia, PA.

After medical school, Dr. Levit completed seven years of residency and fellowship training in cardiovascular disease at Emory University. She runs an active research lab ( funded by the American Heart Association. Her research focuses on translational stem cell therapies for heart disease. She also is the inventor of a medical device to deliver hydrogels to the heart. This pre-clinical stage project is leveraging non-dilutive funding from Atlanta area non-profits (Georgia Research Alliance, and Coulter Foundation) to move towards translation.

She has expertise in clinical cardiology, application of basic science research towards clinical applications, medical device start-ups, and pre-clinical animal models.


Professor and Chair of Radiology, Associate Dean for Research – Emory University School of Medicine

Carolyn Meltzer

Dr. Meltzer is a neuroradiologist and nuclear medicine physician who has enjoyed 17 years of NIH funding for her work in applying novel advanced imaging strategies to better understand brain structure-function relationships in normal aging, late-life depression, and Alzheimer’s disease. She is also involved in oncologic imaging research and, while at the University of Pittsburgh, oversaw the clinical evaluation of the world’s first combined PET/CT scanner. Dr. Meltzer has authored approximately 200 publications and lectured nationally and internationally. She currently serves as a member of the National Advisory Council for Biomedical Imaging and Bioengineering.

Dr. Meltzer joined the Emory School of Medicine in 2005, where she serves as the William P. Timmie Professor and Chair of the Department of Radiology and Imaging Sciences and Associate Dean for Research. She established the Emory Center for Systems Imaging to broadly support the advance of imaging technologies in basic and translational research, including beta testing of the first human combined MRI/PET scanner. Over the past decade she has directed the Research Technologies Program for the Atlanta Clinical and Translational Science Institute.

Reflective of Dr. Meltzer’s service to the field, she has served in numerous national leadership roles including Chair of the Neuroradiology Commission and Chair of the Research Commission on the American College of Radiology’s Board of Chancellors, President of the Academy of Radiology Research, Trustee of the Radiological Society of North America Foundation, and President of the American Society of Neuroradiology. Dr. Meltzer is a fellow of the American College of Radiology and the American College of Neuropsychopharmacology, and in 2013 was inducted into the International Society of Strategic Studies in Radiology.


Director of Cardiovascular Research – Piedmont Heart Institute

Jayne Morgan, Vice Chair

Dr. Jayne Morgan is a Cardiologist with extensive experience in clinical patient management, as well as pharmaceutical and biotech research. For the past 2 decades she has focused on improving the care and quality of life measures for patients from heterogenous populations, including end-of-life patients without further medical options.

Serving in the roles of both Clinical Development and Medical Affairs for global pharmaceutical and device companies for the past 10 years, she has successfully led Phase II and III programs globally, and Phase IV programs in Europe. In these roles, her background includes leadership and accountability for research projects with oversight of a $52 million dollar budget within a $4.5 billion company.

As the driver of the cardio-renal and heart failure programs (sponsored and funded by Solvay Pharmaceuticals), and providing the scientific guidance as a consultant to the MitraClip programs (funded and sponsored by Abbott Vascular), her experience in the design and execution of large international clinical trials for both devices and pharmaceuticals is well established. Acknowledged with both the Solvay Cardio-Metabolic Strategic Paper Award and People to People Ambassadorship for vulnerable global populations, she has selected and led many scientific panel experts including Steering Committees, Adjudication Committees, and Data Safety Monitoring Board Committees, and has also served on regulatory panels for both the FDA and EMA.

Following high school graduation as Valedictorian, Dr. Morgan went on to complete her B.S. degree in Biology and Biochemistry from Spelman College; her M.D. degree from Michigan State University; Internal Medicine Residency from George Washington University; and Cardiology Fellowship at Mount Sinai Medical Center including completion of a Pacemaker Sub-Fellowship. She has treated patients in both rural primary care settings, as well as within academic institutions as the Associate Professor of Medicine at the Cleveland Clinic Florida, and is published in both the American Heart Journal and recognized by the Heart Failure Society for her work on Adenosine Receptor Antagonists. Further, Dr. Morgan has received numerous distinctions in Principles of Radiation Physics, and RadioPharmaceuticals and Chemistry in Nuclear Medicine. In fact, most recently, she served as the CMO (Chief Medical Officer) of the American Chemistry Council where she introduced new stakeholders, advocated for senate bill reforms, and developed a strategy and new direction for their research program including securing funding from the Board of $5 million dollars annually for 4 years.

Dr. Morgan has also served as a 6 year Board member of the Make-A-Wish Foundation of Georgia and Alabama and the Calvary Childrens Home (orphanage). Currently, she is a Founding Member of Biotechnology for Women, member of the AHA (American Heart Association), AMA (American Medical Association), AWMA (American Womens Medical Association), and the ABC (Association of Black Cardiologists). Additionally, she is recognized as an Industry Fellow for the GRA (Georgia Research Alliance) focused on the development and commercialization of biotech and pharma innovations into viable companies and partnerships here in the state of Georgia.

Currently, she is the Director of Cardiovascular Research at the Piedmont Research Institute where she is responsible for all drug, device, and drug/device combination trials in both the Cardiovascular and Peripheral Vascular space. Bringing to an organization over 20+ years of clinical and industry experience, and a demonstrated record of strategic planning, management, and execution of trials to support the medical and scientific platform of an organization, Dr. Morgan is able to leverage a wealth of qualifications in business development, scientific rigor/conduct, medical education, and communication.


Project Engineer, Pediatrics & Quality Engineer – GCMI

Dersi Patel

Dersi Patel joined the GCMI team from Georgia Tech, where she is a biomedical engineering graduate. She leads project management for all pediatric projects and is working alongside pediatric surgeons and clinicians to develop innovative devices for pediatric patients.

In addition, she manages complex electromechanical projects, navigating multiple vendors and resources to help move complex concepts through the development cycle. Patel leads the day-to-day activities of the GCMI Apprentice Program and focuses on QMS organization, design sessions, business development and client communications.


Executive Vice President, System Services – West Tennessee Healthcare

Lisa Piercey

Dr. Lisa Piercey is a West Tennessee native who serves as the Executive Vice President, System Services, at West Tennessee Healthcare. She has a Bachelors of Science in Chemistry from Lipscomb University, a Doctorate of Medicine from East TN State University, Pediatrics Residency and Chief Residency also at East TN State University, and a Masters of Business Administration from Bethel University.

Her current areas of responsibility include administrative oversight of three rural hospitals, Pathways inpatient and outpatient mental health services, inpatient rehabilitation, the West Tennessee Medical Group physician practices, the LIFT Wellness Center, population health and disease management, employer services, SportsPlus outpatient physical therapy clinics, community education, and senior services.

Dr. Piercey’s clinical background is in pediatrics, with a specialization in child abuse pediatrics; as a child abuse pediatrician, Dr. Piercey serves as the Medical Director for the Madison County Child Advocacy Center and is a faculty member at Vanderbilt University School of Medicine. She is board-certified in Pediatrics, Child Abuse Pediatrics, and Healthcare Management. Dr. Piercey enjoys cooking, drumming, traveling, and competing in triathlons, as well as spending time with her husband and four children.


Vice President of Regulatory Affairs – Brookhaven Medical

Grace Powers

Grace Powers is the Vice President of Regulatory Affairs for Brookhaven Medical. She has fifteen years experience in cardiology and urology medical devices including R&D. She has management experience including RA responsibilities related to submissions and compliance. Her RA submission experience includes 510(k), IDE, PMA, HUD, EU Technical Files and Design Dossiers.

Grace previously has managed an International RA team which including Canadian licensing, Australia, Japan, China, Russia, Latin America and other country submissions. She has worked for C.R. Bard, CardioMEMS and Novoste. She also does regulatory consulting for universities, inventors and start-ups. Grace holds a BE in Biomedical Engineering from Vanderbilt University, a MS in Biomedical Engineering from UCLA and an MBA from Georgia Tech. She is RAC US, RAC Europe, and RAC Global certified.


Principal Research Scientist – Georgia Tech Research Institute

Leanne West

Leanne West has participated in several optical system design, development, and evaluation projects in her career. She is author of a book chapter in Technology for Aging, Disability and Independence: Computer and Engineering for Design and Applications, published by John Wiley & Sons and has written a number of papers and given several presentations on assistive technology device development and remote sensing.

Ms. West has licensed her invention of a wireless personal captioning system and brought it to commercialization through her company, Intelligent Access, LLC. She was recognized for her work when she was named one of Georgia’s “40 Under 40” by Georgia Trend magazine in 2004, a listing of the 40 “Best and Brightest” influential Georgians in the business and political communities under 40 years old. Leanne was also selected for the 2008 Leadership GA class, which recognizes leaders for the state of Georgia. She is an active participant at her organization, having served on numerous campus committees and having been the twice-elected Chair of the Georgia Tech Executive Board.


Marketing Director,Strategic Accounts – Molnlycke Healthcare

Allyson Bower-Willner

Ms. Bower-Willner has over 20 years of diverse medical device, NGS (Next Generation Sequencing), biologics and pharmaceutical experience. Her experience ranges from pre-revenue start-ups to multinational Fortune 100 companies, with many in between. Allyson currently serves as the Marketing Director, Strategic Accounts, for Molnlycke Healthcare.

In addition to her work at small medical device companies in the Atlanta area, she previously held roles at Halyard Health, CardioMEMS (now St. Jude Medical), CR Bard and at PRTM (Pittiglio, Rabin, Todd and McGrath, now Price Waterhouse Cooper). Her experience encompasses upstream and downstream marketing, strategy, product development, manufacturing, and quality assurance. Her passion is bringing new and innovative technologies to market. Allyson is a graduate of Rensselaer Polytechnic Institute and Rutgers Graduate School of Management.


Executive Director – AdvaMed Accel

Ashley Wittorf

Ashley Wittorf is the Executive Director of AdvaMed Accel, the division within AdvaMed dedicated to addressing the unique needs and challenges of smaller medtech manufacturers. In this role, she focuses on facilitating a policy environment conducive to capital formation and innovation, advocating for payment and regulatory policies that are favorable to emerging companies, and providing educational opportunities for industry leaders in this entrepreneurial sector.

Prior to joining AdvaMed in early 2012, Ms. Wittorf spent nearly ten years working in the medtech and pharmaceutical industries with a focus on product development, commercialization strategy, and operations – working with both small, venture-backed enterprises and large corporations.

Ms. Wittorf received a master’s degree in bioengineering and a bachelor’s degree in mechanical engineering from the Georgia Institute of Technology, and a Master of Business Administration from the University of Virginia’s Darden School of Business.


Principal – Meunier Carlin & Curfman

Meredith Struby

Meredith has been a practicing patent attorney since 2003, focusing on mechanical, medical devices, and electro-mechanical systems. She advises large and small clients about protecting their innovations and other intellectual property and avoiding the intellectual property of others.

She has extensive experience preparing and prosecuting utility and design patent applications before the U.S. Patent and Trademark Office related to a variety of technology areas, including automotive, building materials, fasteners, children’s toys, medical devices, and textiles. She also works with universities on mechanical related inventions.